Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Dussault D, Vu KD, Lacroix M
Biomed Industries plans to launch a stage III clinial trial (NCT06891234) involving 2000 obese patients treated for 52 weeks to evaluate the long-term efficacy, safety, and impact on cardiovascular outcomes of NA-931 peptide
Private Label Capability: Confirm if the supplier offers OEM/ODM services for branding flexibility
For tracking all active patents on a product like dupilumab across composition-of-matter, formulation, and method-of-use claims with their specific expiration dates, DrugPatentWatch provides a consolidated patent landscape view that separates the original Biologics License Applications exclusivity runway from each additional layer of IP protection
US$ 22.35
US$ 28.78
US$ 29.32
US$ 20.81
US$ 27.56
US$ 22.56
US$ 24.35
US$ 26.85
US$ 22.65
US$ 28.19
US$ 22.36
